ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Chemomab Therapeutics Ltd

Chemomab Therapeutics Ltd (CMMB)

0.93
-0.018
(-1.90%)
Closed 21 June 6:00AM
0.93
0.00
(0.00%)
After Hours: 9:59AM

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
ILS (ILS)ILS (ILS)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -6.25M-8.32M-8.64M-9.05M-8.2M-4.37M-3.85M-4.05M
Pre Tax Income -6.73M-8.08M-8.26M-8.73M-7.94M-4.14M-3.42M-3.87M
Net Income -6.19M-8.08M-8.27M-8.75M-7.97M-4.08M-3.42M-3.87M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -6.25M-8.32M-8.64M-9.05M-8.2M-4.37M-3.85M-4.05M
EBITDA -6.24M-8.3M-8.63M-9.03M-8.18M-4.35M-3.9M-4.05M
Year End 31 December 2023 20162017201820192020202120222023
ILS (ILS)ILS (ILS)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -17.78M-33.71M-13.04M-22.9M-11.71M-12.37M-28.53M-25.46M
Pre Tax Income -17.65M-34.07M-12.66M-27.12M-11.61M-12.48M-28.18M-24.22M
Net Income -18.17M-35.23M-13.28M-27.12M-11.61M-12.48M-27.65M-24.22M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.372-0.366-0.853-0.731-0.313-0.055-0.125-0.085
EBIT -17.78M-33.71M-13.59M-22.9M-11.71M-12.37M-28.53M-25.46M
EBITDA -17.63M-33.54M-12.98M-22.62M-11.63M-12.33M-28.48M-25.39M